Meteospasmyl

Alverine citrate, the active ingredient in Meteospasmyl, is an antispasmodic presented as an oral formulation for oral use. Combined with simethicone, it targets functional gastrointestinal disorders by relaxing smooth‑muscle spasms and reducing intestinal gas, thereby alleviating abdominal pain, bloating and flatulence in adult patients.

GNH USA supplies Meteospasmyl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to WHO‑GMP guidelines and provides batch‑tested products for reliable global distribution, ensuring consistent potency and safety across markets.

Meteospasmyl is used to manage functional gastrointestinal disorders that involve smooth‑muscle spasm and excess intestinal gas.

- Abdominal pain: reduces discomfort by relaxing intestinal smooth muscle. - Bloating: diminishes the sensation of abdominal fullness through antifoaming action. - Flatulence: facilitates the elimination of gas bubbles in the gut. - Irritable bowel syndrome: helps control recurrent abdominal cramps and gas‑related symptoms.

Meteospasmyl is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Headache: transient cranial discomfort. - Dizziness: occasional light‑headed sensation. - Dry mouth: reduced salivation. - Abdominal discomfort: mild cramping.

Serious or Rare Side Effects: - Allergic reactions: rash, itching, or angioedema. - Severe abdominal pain: persistent or worsening pain. - Difficulty breathing: signs of bronchospasm or anaphylaxis. - Swelling of face, lips, or tongue. - Unexplained fainting or loss of consciousness.

Before using Meteospasmyl, consider the following safety measures.

- Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: use with caution; potential transfer to milk is unknown. - Renal impairment: monitor for accumulation and adjust if necessary. - Elderly patients: start with the lowest effective dose and watch for side effects. - Concomitant medications: review all current drugs for possible interactions. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Meteospasmyl may interact with other medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Combined use with other antispasmodics: may increase anticholinergic burden. - Simethicone taken with certain oral antibiotics (e.g., tetracyclines): can reduce antibiotic absorption.

Moderate Interactions (Monitor Closely): - Concurrent anticholinergic agents: monitor for excessive dry mouth or constipation. - Drugs affecting gastrointestinal motility (e.g., prokinetics): observe for additive effects. - Herbal supplements containing peppermint oil: may enhance spasmolytic action. - Over‑the‑counter analgesics (NSAIDs): watch for increased gastrointestinal irritation.